Skip to main contentrtttttt Skip to main content
Integrative Psychiatry

The Science Behind Dopamine: Debunking Detox Myths

By September 24, 2024No Comments

Dopamine is the neurotransmitter in our brain that is responsible for pleasure, reward seeking, and motivation. When dopamine is released, it signals that an action is worth repeating, driving the pursuit of certain activities that offer potential rewards. Importantly, dopamine often spikes in anticipation of a pleasurable stimulus, motivating us to seek it out before we’ve even experienced it.

In a world filled with instant gratification, dopamine-releasing experiences are easy to come by. Common behaviors like scrolling through social media, texting, video gaming, or eating sugary foods are often cited as activities that cause dopamine surges in the brain.

Dopamine Fasting

The practice of “dopamine detoxing” or “dopamine fasting” suggests that taking a break from these pleasurable experiences might help regulate dopamine levels. This school of thought believes that the more dopamine is released, the higher a person’s tolerance becomes, requiring more and more stimulation to feel good. By taking time to avoid activities that are thought to overstimulate the brain’s reward system, a person might feel less attached to compulsive behaviors and be able to refocus their energy toward other habits.

However, this narrative can give dopamine a bit of an unfair reputation. Dopamine is essential for regulating behavior, and pleasure is a fundamental part of the human experience. Instead of eliminating experiences that bring us joy, we should focus on when and why we’re seeking these outlets throughout the day.

Besides, dopamine regulation is complex, involving at least five major pathways, and 5 major dopamine receptor types and numerous subtypes. The release of dopamine is a natural and continuous process, and there is no scientific evidence suggesting that abstaining from pleasurable activities will “reset” the brain’s dopamine system. While taking breaks from overstimulation can help reduce distractions and enhance mindfulness, it won’t permanently change dopamine production. Instead, these breaks can provide cognitive- and mood-boosting benefits that come from mindfully and purposefully engaging with life.

Mindful Engagement

Often, these so-called dopamine-driven behaviors—whether it’s grabbing our phones or reaching for a sugary snack—are actually just impulsive ways to escape from the discomfort of the present moment. Questions to ponder might be, Why are we reaching for these things in the first place? What’s going on in our bodies and minds that’s leading us to seek distraction?

Instead of trying to eliminate pleasurable activities altogether, it is more sustainable to reduce dependence on habits that are used as a way to “exit” connection with the body, including uncomfortable sensations such as anxiety, sadness, and boredom. Being more mindful about how we engage with entertainment, social media, or food can help us stay connected to ourselves and the present moment, making these experiences more fulfilling.

Here are a few simple steps to help support mindful awareness and give us more control over our choices:

Step 1: Pay Attention to Your Emotions.

Take time throughout the day to check in with yourself and ask, “What am I feeling right now?” This helps build awareness of shifting emotional states.

Step 2: Slow Down and Pause.

Before diving into any activity, acknowledge your impulse. Simply saying, “I’m reaching for my phone,” can create a moment of mindfulness.

Step 3: Get Curious About Your Feelings.

Take a moment to explore the emotions behind your impulses. For example, ask yourself, “What feeling is driving my impulse? Am I using social media to avoid feelings of stress, or am I seeking connection? Why am I opposed to being with this emotion? Are there other ways I can address this feeling?”

Step 4: Build Tolerance for Discomfort.

Sometimes, we turn to instant gratification to avoid uncomfortable emotions. Challenge yourself to sit with that discomfort for just 20 more seconds before acting on it. Over time, this builds resilience.

Incorporating mindfulness practices, like meditation, yoga, or deep breathing, can also help with staying connected to the present moment. Activities like gardening or taking a walk in nature are great ways to practice being present while also giving yourself a break from overstimulation. Turning off notifications or setting aside screen-free times during the day can also reduce the urge to disengage.

Conclusion

We’re not always going to be 100% engaged in every moment of life, and that’s okay. Sometimes distractions are necessary to cope with discomfort. The goal isn’t to be perfect, but to be mindful. Understanding dopamine’s role in behavior, making connections to how this feels in our own bodies, and encouraging mindfulness can help us develop long-lasting resiliency and richer day-to-day experiences, including mental clarity, focus, and sense of wellbeing.

Sara Reed, MS, LMFT

Sara Reed is a Licensed Marriage and Family Therapist and CEO of Mind’s iHealth Solutions, a digital health company that provides evidence based and culturally responsible mental health services for underserved groups. As a mental health futurist and clinical researcher, Sara examines the ways culture informs the way we diagnose and treat mental illness. Sara’s prior research work includes participation as a study therapist in psychedelic therapy research at Yale University and the University of Connecticut’s Health Center. Sara was the first Black therapist to provide MDMA-assisted psychotherapy in a clinical trial and continues to engage in ongoing advocacy work around health equity in psychedelic medicine.

https://psychiatryinstitute.com/wp-content/uploads/2019/11/Jeffrey-Guss.png

Jeffrey Guss, MD is a psychiatrist, psychoanalyst, and researcher with specializations in psychoanalytic therapy and the treatment of substance use disorders. He was Co-Principal Investigator and Director of Psychedelic Therapy Training for the NYU School of Medicine’s study on psychedelic-assisted psychotherapy in the treatment of cancer-related existential distress, which was published in Journal of Psychopharmacology, 2016. He currently is a study therapist in the NYU study on Psychedelic-Assisted therapy in the treatment of Alcoholism, a collaborator with Yale University’s study on psychedelic-assisted therapy for Major Depressive Disorder and a study therapist with the MAPS (Multidisciplinary Association for Psychedelic Studies) study on treatment of Post Traumatic Stress Disorder with Psychedelic-Assisted Psychotherapy. 

Dr. Guss is interested in the integration of psychedelic therapies with contemporary psychoanalytic theory and has published in Studies in Gender and Sexuality and Psychoanalysis, Culture and Society. He has published (with Elizabeth Nielson, PhD) a paper on “the influence of therapists’ first had experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training” in The Journal of Psychedelic Studies, August, 2018. He is an Instructor and Mentor with the California Institute of Integral Studies’ Center for Psychedelic Therapies and Supervisor in NYU’s Fellowship in Addiction Psychiatry. 

Dr. Guss maintains a private practice in New York City.

Will Van Derveer, MD

Will Van Derveer, MD is Co-Founder of Integrative Psychiatry Institute and Integrative Psychiatry Centers. Dr. Van Derveer was co-investigator on a phase 2 MAPS study of Psychedelic-assisted psychotherapy for treatment-resistant PTSD, and co-authored the publication of this study in 2018. He has also provided Psychedelic-assisted psychotherapy in two MAPS training studies. An active provider of KAP at his clinic in Boulder, CO, he has been teaching others KAP therapy for several years. Dr. Van Derveer contributed a chapter on mescaline in the 2021 "Handbook of Medical Hallucinogens" (edited by Charles Grob and Jim Grigsby). He is co-host of the Higher Practice Podcast.

Dr. Van Derveer regards unresolved emotional trauma as the most significant under-recognized root cause of psychiatric symptoms in integrative psychiatry practice, along with gut issues, hormone imbalances, inflammation, mitochondrial dysfunction, and other functional medicine challenges. He is trained in Somatic Experiencing, EMDR, Internal Family Systems, and other psychotherapy techniques. His current clinical passion is psychedelic-assisted psychotherapy, which he mentors interested doctors in providing. An avid meditator, he has been a meditation instructor since 2004.

For the past several years Dr. Van Derveer has taught psychiatrists and other psychiatric providers integrative psychiatry in a number of settings, including course directing the CU psychiatry residents’ course as well as with Scott Shannon and Janet Settle at the Psychiatry MasterClass.


Scott has been a student of consciousness since his honors thesis on that topic at the University of Arizona in the 1970s under the tutelage of Dr. Andrew Weil. Following medical school, Scott studied Jungian therapy and acupuncture while working as a primary care physician in a rural area for four years. Psychedelic-assisted psychotherapy became a facet of his practice before this medicine was scheduled in 1985. He then completed a psychiatry residency at Columbia program in New York. Scott studied cross-cultural psychiatry and completed a child/adolescent psychiatry fellowship at the University of New Mexico.

In 2010 he founded Wholeness Center in Fort Collins. This innovative clinic provides cross-disciplinary evaluation and care for all mental health concerns. Scott serves as a site Principal Investigator and therapist for the Phase III trial of psychedelic-assisted psychotherapy for PTSD sponsored by (MAPS). He has also published numerous articles about his research on (CBD) in mental health. Currently, Scott works extensively with psychedelic-assisted-psychotherapy. He lectures all over the world to professional groups interested in a deeper look at mental health issues, safer tools, and a paradigm-shifting perspective about transformative care.

Will Van Derveer, MD is co-founder of Integrative Psychiatry Institute (IPI), along with friend and colleague Keith Kurlander, MA. He co-created IPI as an expression of what he stands for. First, that anyone can heal, and second that we medical providers must embrace our own healing journeys in order to fully command our potency as healers.

Dr. Van Derveer spent the last 20 years innovating and testing a comprehensive approach to addressing psychiatric challenges which transcends the conventional model he learned in medical school at Vanderbilt University and residency at University of Colorado, while deeply engaging his own healing path.

He founded the Integrative Psychiatric Healing Center in in 2001 in Boulder, CO, where he currently practices. Dr. Van Derveer regards unresolved emotional trauma as the most significant root cause of psychiatric symptoms in integrative psychiatry practice, along with gut issues, hormone imbalances, inflammation, mitochondrial dysfunction, and other functional medicine challenges. He is trained in Somatic Experiencing, EMDR, Internal Family Systems, and other psychotherapy techniques. His current clinical passion is psychedelic-assisted psychotherapy, which he mentors interested doctors in providing. An avid meditator, he has been a meditation instructor since 2004.

For the past several years Dr. Van Derveer has taught psychiatrists and other psychiatric providers integrative psychiatry in a number of settings, including course directing the CU psychiatry residents’ course as well as with Scott Shannon and Janet Settle at the Psychiatry MasterClass. In addition to his clinical work and teaching, he was co-investigator in 2016 a Phase II randomized clinical trial, sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS). He continues to support this protocol, now in a Phase III clinical trial under break-through designation by FDA.

Dr. Van Derveer is a diplomate of the American Board of Integrative and Holistic Medicine (ABoIHM) since 2013, and he was board certified in the first wave of diplomates of the new American Board of Integrative Medicine (ABIM) in 2016.